TrialFrontiers in immunology2026

Everolimus-based immunosuppression induces alloreactive regulatory T cell expansion combined with loss of alloreactive effector T cells.

Nicolle H R Litjens et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.